Nevertheless, RRSO is associated with a significant reduction in PBC risk in BRCA2 carriers alone and improved breast cancer survival in BRCA1 and BRCA2 carriers previously diagnosed with breast cancer [16]. This evidence concerns the gene BRCA1 and breast carcinoma.